Phenylboronic Acid

Phenylboronic Acid

SCHEMBL4618848

O=C(O)C(F)F.OB(O)c1ccccc1

nearest known ligand 0.64

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA4 P22748 1/20 0.64
▸ CA6 P23280 1/20 0.64
▸ CA5A P35218 1/20 0.64
▸ CA7 P43166 1/20 0.64
▸ ENPP2 Q13822 1/20 0.64
▸ CA14 Q9ULX7 1/20 0.64
▸ CA5B Q9Y2D0 1/20 0.64
▸ CA1 P00915 2/20 0.48
▸ CA2 P00918 2/20 0.48
▸ MGLL Q99685 2/20 0.48
▸ PCSK9 Q8NBP7 1/20 0.44
▸ ORAI1 Q96D31 1/20 0.44
▸ ORAI2 Q96SN7 1/20 0.44
▸ ORAI3 Q9BRQ5 1/20 0.44
▸ TRPV6 Q9H1D0 1/20 0.44
▸ P4HB P07237 1/20 0.42
▸ TRPV1 Q8NER1 1/20 0.40
▸ CYP2D6 P10635 1/20 0.39
▸ SRC P12931 1/20 0.39
▸ LMNA P02545 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phenylboronic Acid SCHEMBL4453 0.80 — —
Phenylboronic Acid SCHEMBL8628436 0.80 ENPP2 (1.00) CA4CA6CA5ACA7ENPP2
Phenylboronic Acid SCHEMBL6701482 0.78 ENPP2 (0.74) CA4CA6CA5ACA7ENPP2
Phenylboronic Acid SCHEMBL28944102 0.78 ENPP2 (0.74) CA4CA6CA5ACA7ENPP2
Phenylboronic Acid SCHEMBL23824843 0.78 ENPP2 (0.74) CA4CA6CA5ACA7ENPP2
Phenylboronic Acid SCHEMBL17202516 0.78 ENPP2 (0.82) CA4CA6CA5ACA7ENPP2
Phenylboronic Acid SCHEMBL4446883 0.77 ENPP2 (0.93) CA4CA6CA5ACA7ENPP2
Phenylboronic Acid SCHEMBL22683683 0.77 ENPP2 (0.93) CA4CA6CA5ACA7ENPP2
Phenylboronic Acid SCHEMBL21820815 0.77 ENPP2 (0.93) CA4CA6CA5ACA7ENPP2
Phenylboronic Acid SCHEMBL3176519 0.77 ENPP2 (0.93) CA4CA6CA5ACA7ENPP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1891019-A2 2,6-SUBSTITUTED-4-MONOSUBSTITUTEDAMINO-PYRIMIDINE AS PROSTAGLANDIN D2 RECEPTOR ANTAGONISTS Aventis Pharmaceuticals Inc. (US) 2008-02-27 — — EP disclosed
WO-2006044732-A2 2, 6-SUBSTITUTED-4-MONOSUBSTITUTEDAMINO-PYRIMIDINE AS PROSTAGLANDIN D2 RECEPTOR ANTAGONISTS AVENTIS PHARMACEUTICALS INC. (US) 2006-04-27 — — WO disclosed
Send feedback